HOME >> BIOLOGY >> NEWS
Evaluation Of The Two Types Of Cardiac Pacemakers Indicates Only Modest Differences In Value

ctional status and long-term cardiac function.

The researchers did see better long-term cardiac functional status in patients with dual chamber pacemakers, but this observation, they say, demonstrates the complexities inherent in measuring quality of life in the elderly. "While it is clear from our results that dual chamber pacing is associated with long-term improvements in cardiovascular function of over time," said Goldman, "aging and the development or worsening of other diseases may overwhelm the modest improvements in cardiovascular functional class and minimize the long-term effect on generic quality of life."

The pacemakers have traditionally been associated with different advantages. The single chamber ventricular pacemaker is less expensive, easier to implant, and has a longer service life than the dual chamber pacemaker; most important, there often are fewer complications associated with the pacemaker itself. Dual chamber pacemakers, on the other hand, offer the theoretical benefit of mimicking the normal electrical sequence of the heart, pacing the atrium first and the ventricular chamber second.

"The question," said Goldman, "has been whether the benefit of the dual chamber pacemaker in terms of heart function and other complications warrants the extra difficulty in placement, shorter battery life and potential risk of complications for the pacemaker itself, as well as the extra cost. The answer seems to be that in many cases it is not."

The 29-center study, called the Pacemaker Selection in the Elderly Trial, involved patients diagnosed with either sinus node dysfunction, a condition in which the heart beat is not initiated at the appropriate rate, or atrial-ventricular block, in which the heart beat is initiated at the appropriate rate but does not make it through the electrical system. Patients were assessed at three, nine and 18 months after enrollment in the study.
'"/>

Contact: Jennifer O'Brien
jobrien@itsa.ucsf.edu
(415) 476-2557
University of California - San Francisco
16-Apr-1998


Page: 1 2 3

Related biology news :

1. Penn State Wetlands Project Seeks Scientific Evaluation Criteria
2. Research Team Finds Gene Causing Two Types Of Muscular Dystrophy
3. Cardiac arrest may hinder ability to learn certain tasks
4. Cardiac stress tests may indicate if blockages will recur after angioplasty with stent implant
5. Cardiac surgery patients at higher risk
6. Sudden Cardiac Death May Run In Families
7. New Company Formed Through Licensing Of Cardiac-Hypertrophy Technology From Texas Institutions
8. Cardiac Clinical Trial Studies Use of Antibiotic In Preventing Heart Attack
9. Strategic Placement Of Automated External Defibrillators May Help Save Lives Of People Who Go Into Cardiac Arrest
10. Family Ties To Sudden Cardiac Arrest; Study Finds Risk Goes Up 50 Percent
11. Study Reviews Medication Use In Elderly Cardiac Patients After Discharge

Post Your Comments:
(Date:8/28/2015)... , August 28, 2015 According ... Training Market by Assessment Type (Pen & Paper Based, ... Training, Corporate Learning, Academic Research), Vertical and Region - ... and Training Market to grow from USD 2.4 Billion ... a Compound Annual Growth Rate (CAGR) of 25.6% from ...
(Date:8/26/2015)... India , August 26, 2015 ... Three, Four, and Five Factor), Application (Travel & Immigration, ... Geography - Global Forecast to 2020", published by MarketsandMarkets, ... Billion by 2020, growing at a CAGR of 17.7% ... Tables and 82 F igures spread through 169 ...
(Date:8/25/2015)... and BELLEVUE, Wash. , ... in advanced robotic systems, announced today it will unveil ... ground vehicle (UGV), at the National Tactical Officers Association ... The Guardian S is the first-ever commercially ... of years of research and in-field trials and is ...
Breaking Biology News(10 mins):Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 2Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 3Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3
(Date:8/31/2015)... ... August 31, 2015 , ... There’s a new treatment option for excessive ... commercially available new FDA approved system in the last 14 years, and the only ... Amenorrhea (zero bleeding) rate of 66%, the high Patient Satisfaction rate of 98%, and ...
(Date:8/31/2015)... ... ... Proove Biosciences, Inc. is a finalist for the Outstanding Tech Company category ... in its 22nd year, this premier awards event celebrates the best in Orange County’s ... the world. The OC Tech Alliance will announce all winners at a gala dinner ...
(Date:8/30/2015)... England , August 31, 2015 /PRNewswire/ ... 51-jährige Wartezeit   einer Frau   für chirurgische   ... Alter von 7-90   werden für eine ... Programm soll 1200 Frauen behandeln und die Anzahl ausgebildeter ... Astellas gab heute bekannt, dass  Action ...
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Global & USA BioSimilar ... The highly awaited US Biosimilar market will ... awaited filigrastim biologic, Zarxio. How will the global market ... author reveals that biosimilars could save the US economy ...
Breaking Biology Technology:U.S. FDA Approves Minerva Endometrial Ablation System 2U.S. FDA Approves Minerva Endometrial Ablation System 3Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 2Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 3Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 4Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 2Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 3Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 4Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 5Global & USA BioSimilar Market Analysis Report 2015-2021 2Global & USA BioSimilar Market Analysis Report 2015-2021 3
Cached News: